SCHIMMEL PAUL 4
4 · aTYR PHARMA INC · Filed Oct 9, 2025
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
SCHIMMEL PAUL
Director
Transactions
- Purchase
Common Stock
2025-10-08$0.90/sh+682,001$612,437→ 1,095,024 total(indirect: See Footnote) - Purchase
Common Stock
2025-10-09$0.94/sh+317,999$299,364→ 1,413,023 total(indirect: See Footnote)
Holdings
- 8,890
Common Stock
- 679,143(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.8536 to $0.95 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
- [F3]Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.93 to $0.95 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F4]These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.